CM Management, LLC
13F Reported Value
ⓘ$119.6M
Holdings
71
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
CM Management, LLC disclosed 71 positions worth $119.6M in its Form 13F-HR for Q1 2026, led by $ALCO (ALICO, INC.) at 6.9% of the equity portfolio, followed by $RIGL and $RPRX. During the quarter the fund opened 17 new positions and exited 8 — including a new stake in $CRL and a full exit from $TGB. The portfolio is most concentrated in Healthcare (39.7% of disclosed assets). All figures are sourced directly from CM Management, LLC’s Form 13F-HR filing with the SEC under CIK 1841857.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 22.5#2,636
Quality
$8.3M200,000 sh - 73.9#174
Quality
$6.4M235,000 sh - —
Quality
$6.0M125,000 sh - 58.1
Quality
$4.6M650,000 sh - 31.4
Quality
$4.5M330,000 sh - 69.9
Quality
$4.4M450,000 sh - 42.9
Quality
$3.5M2,100,000 sh - $3.0M17,500 sh
- 36.5
Quality
$3.0M110,000 sh - 52.4
Quality
$2.8M190,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 22.5#2,636 | $8.3M | 200,000 | |
| 73.9#174 | $6.4M | 235,000 | |
| — | $6.0M | 125,000 | |
| 58.1 | $4.6M | 650,000 | |
| 31.4 | $4.5M | 330,000 | |
| 69.9 | $4.4M | 450,000 | |
| 42.9 | $3.5M | 2,100,000 | |
| 47.1 | $3.0M | 17,500 | |
| 36.5 | $3.0M | 110,000 | |
| 52.4 | $2.8M | 190,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of CM Management, LLC's 71 positions.
Showing top 10 of 71 holdings.
Sector Allocation
Healthcare
$47.5M
Financials
$16.3M
Industrials
$16.0M
Consumer Staples
$12.1M
Technology
$11.7M
Consumer Discretionary
$8.5M
Real Estate
$4.7M
Materials
$1.9M
Full Holdings — CM Management, LLC (Q1 2026)
All 71 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | ALICO, INC. | $8.3M | 6.9% | +0% | 22.5 | |
| 2 | RIGEL PHARMACEUTICALS INC | $6.4M | 5.3% | +4% | 73.9 | |
| 3 | Royalty Pharma plc | $6.0M | 5.0% | +67% | — | |
| 4 | RADIANT LOGISTICS, INC | $4.6M | 3.8% | +0% | 58.1 | |
| 5 | INTEST CORP | $4.5M | 3.8% | -21% | 31.4 | |
| 6 | BGC Group, Inc. | $4.4M | 3.7% | +13% | 69.9 | |
| 7 | Coherus Oncology, Inc. | $3.5M | 3.0% | +0% | 42.9 | |
| 8 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $3.0M | 2.5% | NEW | 47.1 | |
| 9 | MARINEMAX INC | $3.0M | 2.5% | +10% | 36.5 | |
| 10 | NEWMARK GROUP, INC. | $2.8M | 2.4% | +0% | 52.4 | |
| 11 | Park Hotels & Resorts Inc. | $2.6M | 2.2% | +11% | 40.3 | |
| 12 | Organon & Co. | $2.4M | 2.0% | +100% | 55.1 | |
| 13 | Viatris Inc | $2.4M | 2.0% | -13% | 47.1 | |
| 14 | REPUBLIC BANCORP INC /KY/ | $2.3M | 1.9% | +0% | 66.9 | |
| 15 | ARKO Corp. | $2.1M | 1.7% | -6% | 41.8 | |
| 16 | Eledon Pharmaceuticals, Inc. | $2.0M | 1.7% | +0% | — | |
| 17 | EVEREST GROUP, LTD. | $2.0M | 1.6% | NEW | — | |
| 18 | Atea Pharmaceuticals, Inc. | $1.9M | 1.6% | +0% | — | |
| 19 | FIRST FINANCIAL CORP /IN/ | $1.9M | 1.6% | +33% | — | |
| 20 | Bristow Group Inc. | $1.9M | 1.6% | +0% | 60.4 | |
| 21 | ALASKA AIR GROUP, INC. | $1.8M | 1.5% | NEW | 56.3 | |
| 22 | INNOSPEC INC. | $1.8M | 1.5% | +20% | 50 | |
| 23 | HP INC | $1.7M | 1.4% | NEW | 58.9 | |
| 24 | Copa Holdings, S.A. | $1.7M | 1.4% | +500% | — | |
| 25 | Evolus, Inc. | $1.6M | 1.4% | +60% | 30 | |
| 26 | IOVANCE BIOTHERAPEUTICS, INC. | $1.6M | 1.3% | +13% | 30.6 | |
| 27 | PagerDuty, Inc. | $1.6M | 1.3% | +67% | 66.6 | |
| 28 | Coya Therapeutics, Inc. | $1.5M | 1.2% | +7% | — | |
| 29 | ARK RESTAURANTS CORP | $1.5M | 1.2% | +0% | 24.4 | |
| 30 | SHOULDER INNOVATIONS, INC. | $1.5M | 1.2% | +300% | 46.5 | |
| 31 | Sabre Corp | $1.4M | 1.2% | +25% | 56.2 | |
| 32 | Cognyte Software Ltd. | $1.4M | 1.2% | +9% | — | |
| 33 | ClearPoint Neuro, Inc. | $1.4M | 1.1% | +88% | 28.8 | |
| 34 | Enovis CORP | $1.4M | 1.1% | NEW | 40.5 | |
| 35 | Victory Capital Holdings, Inc. | $1.3M | 1.1% | NEW | 75.5 | |
| 36 | COLUMBUS MCKINNON CORP | $1.3M | 1.1% | +64% | 42.3 | |
| 37 | XOMA Royalty Corp | $1.3M | 1.1% | +0% | 74 | |
| 38 | IRONWOOD PHARMACEUTICALS INC | $1.2M | 1.0% | NEW | 55.9 | |
| 39 | PRUDENTIAL FINANCIAL INC | $1.2M | 1.0% | NEW | 58.6 | |
| 40 | SCOTTS MIRACLE-GRO CO | $1.2M | 1.0% | +0% | 74.9 | |
| 41 | AMCON DISTRIBUTING CO | $1.2M | 1.0% | +50% | 44.6 | |
| 42 | 1ST SOURCE CORP | $1.2M | 1.0% | +0% | — | |
| 43 | Beacon Financial Corp | $1.2M | 1.0% | -17% | 46.9 | |
| 44 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | $1.2M | 1.0% | -17% | 45.1 | |
| 45 | Profound Medical Corp. | $1.1M | 0.9% | +119% | — | |
| 46 | MICROSOFT CORP | $1.1M | 0.9% | NEW | 83.7 | |
| 47 | AMAZON COM INC | $1.0M | 0.9% | NEW | 74.6 | |
| 48 | HELEN OF TROY LTD | $1.0M | 0.8% | +367% | 34.9 | |
| 49 | TENNANT CO | $996,000 | 0.8% | NEW | 43.6 | |
| 50 | HERC HOLDINGS INC | $995,500 | 0.8% | NEW | 56.7 | |
| 51 | Churchill Downs Inc | $898,300 | 0.8% | NEW | 65.5 | |
| 52 | Cytosorbents Corp | $836,142 | 0.7% | +0% | 19.5 | |
| 53 | EURONET WORLDWIDE, INC. | $829,625 | 0.7% | +0% | 58.3 | |
| 54 | HERON THERAPEUTICS, INC. /DE/ | $800,100 | 0.7% | +33% | 30.6 | |
| 55 | NEWELL BRANDS INC. | $686,000 | 0.6% | +0% | 41.3 | |
| 56 | AVIAT NETWORKS, INC. | $678,300 | 0.6% | +50% | 45.4 | |
| 57 | Service Properties Trust | $677,500 | 0.6% | +25% | 35.7 | |
| 58 | Assertio Holdings, Inc. | $667,100 | 0.6% | -30% | 27.2 | |
| 59 | FRACTYL HEALTH, INC. | $640,920 | 0.5% | +75% | — | |
| 60 | GENELUX Corp | $605,000 | 0.5% | NEW | — | |
| 61 | OS Therapies Inc | $564,000 | 0.5% | +0% | — | |
| 62 | STANLEY BLACK & DECKER, INC. | $532,950 | 0.5% | NEW | 52.4 | |
| 63 | Keurig Dr Pepper Inc. | $526,600 | 0.4% | -80% | 63.1 | |
| 64 | WINNEBAGO INDUSTRIES INC | $464,850 | 0.4% | NEW | 46.6 | |
| 65 | Camping World Holdings, Inc. | $409,800 | 0.3% | NEW | 45.4 | |
| 66 | enVVeno Medical Corp | $361,782 | 0.3% | -97% | — | |
| 67 | Lantern Pharma Inc. | $342,500 | 0.3% | +11% | — | |
| 68 | COGNITION THERAPEUTICS INC | $303,800 | 0.3% | +100% | — | |
| 69 | Elicio Therapeutics, Inc. | $267,250 | 0.2% | +0% | — | |
| 70 | BioCardia, Inc. | $157,300 | 0.1% | +0% | — | |
| 71 | CURIS INC | $82,095 | 0.1% | -54% | — |
New Positions (17)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for CM Management, LLC including:
Track CM Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for CM Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: CM Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For CM Management, LLC (SEC CIK: 1841857), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in CM Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.